https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00405-3/fulltext
"Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis...Strikingly, patients treated with L-arginine exhibited a significantly reduced in-hospital stay vs placebo, with a median (interquartile range 25th,75th percentile) of 46 days (45,46) in the placebo group vs 25 days (21,26) in the L-arginine group (p < 0.0001)"
"Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis...Strikingly, patients treated with L-arginine exhibited a significantly reduced in-hospital stay vs placebo, with a median (interquartile range 25th,75th percentile) of 46 days (45,46) in the placebo group vs 25 days (21,26) in the L-arginine group (p < 0.0001)"
"COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25(OH)D3: Results of a systematic review and meta-analysis"
https://www.medrxiv.org/content/10.1101/2021.09.22.21263977v1
https://www.medrxiv.org/content/10.1101/2021.09.22.21263977v1
medRxiv
COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be…
Background Much research shows that blood calcidiol (25(OH)D3) levels correlate strongly with SARS-CoV-2 infection severity. There is open discussion regarding whether low D3 is caused by the infection or if deficiency negatively affects immune defense. The…
"severe COVID-19 disease ... three basic pathologic processes, namely a pulmonary macrophage activation syndrome with uncontrolled inflammation, a complement-mediated endothelialitis together with a procoagulant state with a thrombotic microangiopathy"
https://www.bmj.com/content/374/bmj.n2101
https://www.bmj.com/content/374/bmj.n2101
The BMJ
Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
The US CDC estimates that SARS-CoV-2 has infected more than 100 million Americans, and evidence is mounting that natural immunity is at least as protective as vaccination. Yet public health leadership says everyone needs the vaccine. Jennifer Block investigates…
This media is not supported in your browser
VIEW IN TELEGRAM
The Director of https://clinicaltrials.gov, Deborah A. Zarin, explains that Clinical Trial failures will have to be made public in the 'New World Order' and that 'no one is happy about that'. She also makes recommendations to journalists on how to report Vaccine Adverse Reactions.
Air Date: November 2nd, 2016
Source (@ 3h47m): https://videocast.nih.gov/watch=19844
Air Date: November 2nd, 2016
Source (@ 3h47m): https://videocast.nih.gov/watch=19844
This media is not supported in your browser
VIEW IN TELEGRAM
During an NLM Board of Regents Meeting at the NIH, Dr. Suzanne Bakken discussed their Google Partnership to change search strategies on vaccines and other topics.
Air Date: May 14th, 2019
Source: https://videocast.nih.gov/watch=31875
Air Date: May 14th, 2019
Source: https://videocast.nih.gov/watch=31875
this is still the 'official data' and we know from the Lazarus/Harvard Medical study that VAERS is capturing < 1%.....when you extrapolate their findings into the official VAERS data....it's quite staggering, to say the least.
This media is not supported in your browser
VIEW IN TELEGRAM
At the Pathological Institute in Reutlingen, Scientists analyze unknown components moving inside the COVID-19 Vaccines
Air Date: September 20th, 2021
Source (@ 1h27m): https://pathologie-konferenz.de/en/
Air Date: September 20th, 2021
Source (@ 1h27m): https://pathologie-konferenz.de/en/
Bill Gates/GAVI published an article (https://www.gavi.org/vaccineswork/next-pandemic/marburg) on 22-Apr-2021 titled “The next pandemic: Marburg?”. There have been numerous Mainstream Media articles highlighting an upcoming threat Marburg and referencing the WHO in recent months. [see below for a multitude of articles]
Marburg Virus (https://en.wikipedia.org/wiki/Marburg_virus) is a relatively rare haemorrhagic fever which was first described in 1967, there have only been a total of 376 related deaths, and only 16 deaths since 2005.
Primerdesign developed a one-step Real-Time PCR test, genesig, (https://www.genesig.com/assets/files/mbgv_std.pdf) in 2018 for Marburg haemorrhagic fever. Why would they develop a test in 2018 for an illness which has not had a major outbreak since 2005?
Soligenix is currently rushing to trial a ricin-rich vaccine, RiVax, for Marburg haemorrhagic fever. RiVax has Fast Track designation for the prevention of ricin intoxication by the US FDA. Approval of ricin toxin vaccine will utilize the FDA Animal Rule (https://www.fda.gov/drugs/nda-and-bla-approvals/animal-rule-approvals) to eliminate the phase 1, 2 & 3 trials. Why such a rush now, to trial a vaccine for which there has only been a total of 376 deaths since 1967 and only 16 deaths since 2005? The main component of the Rivax vaccine is Ricin.
Ricin (https://en.wikipedia.org/wiki/Ricin) is a lectin and a highly potent toxin produced in the seeds of the castor oil plant. Ricin is very toxic if inhaled, injected, or ingested. It acts as a toxin by inhibiting protein synthesis. It prevents cells from assembling various amino acids into proteins according to the messages it receives from messenger RNA in a process conducted by the cell’s ribosome (the protein-making machinery) – that is, the most basic level of cell metabolism, essential to all living cells and thus to life itself.
Soligenix shareholders include BlacRrock Fund Advisors, Goldman Sachs & Co. LLC, etc. (https://money.cnn.com/quote/shareholders/shareholders.html?symb=SNGX&subView=institutional)
A paper titled Asymptomatic Infection of Marburg Virus was published by the NIH in January 2021. (https://pubmed.ncbi.nlm.nih.gov/33157026/)
Marburg Virus (https://en.wikipedia.org/wiki/Marburg_virus) is a relatively rare haemorrhagic fever which was first described in 1967, there have only been a total of 376 related deaths, and only 16 deaths since 2005.
Primerdesign developed a one-step Real-Time PCR test, genesig, (https://www.genesig.com/assets/files/mbgv_std.pdf) in 2018 for Marburg haemorrhagic fever. Why would they develop a test in 2018 for an illness which has not had a major outbreak since 2005?
Soligenix is currently rushing to trial a ricin-rich vaccine, RiVax, for Marburg haemorrhagic fever. RiVax has Fast Track designation for the prevention of ricin intoxication by the US FDA. Approval of ricin toxin vaccine will utilize the FDA Animal Rule (https://www.fda.gov/drugs/nda-and-bla-approvals/animal-rule-approvals) to eliminate the phase 1, 2 & 3 trials. Why such a rush now, to trial a vaccine for which there has only been a total of 376 deaths since 1967 and only 16 deaths since 2005? The main component of the Rivax vaccine is Ricin.
Ricin (https://en.wikipedia.org/wiki/Ricin) is a lectin and a highly potent toxin produced in the seeds of the castor oil plant. Ricin is very toxic if inhaled, injected, or ingested. It acts as a toxin by inhibiting protein synthesis. It prevents cells from assembling various amino acids into proteins according to the messages it receives from messenger RNA in a process conducted by the cell’s ribosome (the protein-making machinery) – that is, the most basic level of cell metabolism, essential to all living cells and thus to life itself.
Soligenix shareholders include BlacRrock Fund Advisors, Goldman Sachs & Co. LLC, etc. (https://money.cnn.com/quote/shareholders/shareholders.html?symb=SNGX&subView=institutional)
A paper titled Asymptomatic Infection of Marburg Virus was published by the NIH in January 2021. (https://pubmed.ncbi.nlm.nih.gov/33157026/)
www.gavi.org
The next pandemic: Marburg?
A cousin of Ebola, Marburg can kill nine out of ten people it infects, and international travel has taken it from Africa to Europe twice in the past 40 years. The virus has just hit Equatorial Guinea for the first time ever – what does this mean for the rest…